Stay updated on Nivolumab After SIRT for HCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab After SIRT for HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab After SIRT for HCC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The NASIR-HCC study page shows only minor UI adjustments (spacing/formatting) with no changes to study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:19:42.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.
    Difference
    3%
    Check dated 2025-10-06T04:16:06.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes provided.
    Difference
    0.1%
    Check dated 2025-09-28T23:38:19.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Updated revision from v3.0.1 to v3.0.2 and removed the Back to Top element. Overall, core content, pricing, stock/slot availability, and proper nouns remain unchanged.
    Difference
    0.2%
    Check dated 2025-09-14T10:00:19.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T07:58:26.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location in Barakaldo, Spain, as well as new research references related to liver cancer treatment. Notably, several terms related to immunological agents have been removed.
    Difference
    7%
    Check dated 2025-08-31T01:06:47.000Z thumbnail image

Stay in the know with updates to Nivolumab After SIRT for HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab After SIRT for HCC Clinical Trial page.